22 results for author:"Leuschner I." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Senanayake U., Das S., Vesely P., Alzoughbi W., Frohlich L.F., Chowdhury P., Leuschner I., Hoefler G., Guertl B. Carcinogenesis 33:1014-1021(2012) · Mapped (4) |
| Absence of BRAF mutation in pediatric and adolescent germ cell tumors indicate biological differences to adult tumors. Masque-Soler N., Szczepanowski M., Leuschner I., Vokuhl C., Haag J., Calaminus G., Klapper W. Pediatr Blood Cancer 59:732-735(2012) · Mapped (3) |
| Activation of beta-catenin is a late event in the pathogenesis of nephroblastomas and rarely correlated with genetic changes of the APC gene. Grill C., Sunitsch S., Hatz M., Hauser-Kronberger C., Leuschner I., Hoefler G., Guertl B. Pathology 43:702-706(2011) · Mapped (14) |
| Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy. Tonelli R., McIntyre A., Camerin C., Walters Z.S., Di Leo K., Selfe J., Purgato S., Missiaglia E., Tortori A., Renshaw J. et al. Clin. Cancer Res. 18:796-807(2012) · Mapped (7) |
| Lim1, an embryonal transcription factor, is absent in multicystic renal dysplasia, but reactivated in nephroblastomas. Guertl B., Senanayake U., Nusshold E., Leuschner I., Mannweiler S., Ebner B., Hoefler G. Pathobiology 78:210-219(2011) · Mapped (3) |
| CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. Walter D., Satheesha S., Albrecht P., Bornhauser B.C., D'Alessandro V., Oesch S.M., Rehrauer H., Leuschner I., Koscielniak E., Gengler C. et al. PLoS ONE 6:e19506-e19506(2011) · Mapped (4) |
| Analysis of the adenomatous polyposis coli (APC) gene in childhood and adolescent germ cell tumors. Okpanyi V., Schneider D.T., Zahn S., Sievers S., Calaminus G., Nicholson J.C., Palmer R.D., Leuschner I., Borkhardt A., Schonberger S. Pediatr Blood Cancer 56:384-391(2011) · Mapped (10) |
| The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumors. Koos B., Jeibmann A., Lunenburger H., Mertsch S., Nupponen N.N., Roselli A., Leuschner I., Paulus W., Fruhwald M.C., Hasselblatt M. Cancer 116:5075-5081(2010) · Mapped (13) |
| Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor. Williams R.D., Al-Saadi R., Chagtai T., Popov S., Messahel B., Sebire N., Gessler M., Wegert J., Graf N., Leuschner I. et al. Clin. Cancer Res. 16:2036-2045(2010) · Mapped (13) |
| High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma. Carr-Wilkinson J., O'Toole K., Wood K.M., Challen C.C., Baker A.G., Board J.R., Evans L., Cole M., Cheung N.K., Boos J. et al. Clin. Cancer Res. 16:1108-1118(2010) · Mapped (32) |
| Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Schneppenheim R., Fruhwald M.C., Gesk S., Hasselblatt M., Jeibmann A., Kordes U., Kreuz M., Leuschner I., Martin Subero J.I., Obser T. et al. Am. J. Hum. Genet. 86:279-284(2010) · UniProtKB (1) · Mapped (8) |
| Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Kordes U., Gesk S., Fruhwald M.C., Graf N., Leuschner I., Hasselblatt M., Jeibmann A., Oyen F., Peters O., Pietsch T. et al. Genes Chromosomes Cancer 49:176-181(2010) · Mapped (8) |
| WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact. Wegert J., Wittmann S., Leuschner I., Geissinger E., Graf N., Gessler M. Genes Chromosomes Cancer 48:1102-1111(2009) · Mapped (1) |
| Is predisposition for nephroblastoma linked to polymorphisms of the WTX gene? Guertl B., Leuschner I., Guelly C., Ebner B., Kronberger C., Hoefler G. Pathol. Oncol. Res. 16:189-191(2010) · Mapped (1) |
| Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival. Hartmann W., Kuchler J., Koch A., Friedrichs N., Waha A., Endl E., Czerwitzki J., Metzger D., Steiner S., Wurst P. et al. Clin. Cancer Res. 15:4538-4545(2009) · Mapped (16) |
| Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics. Grass B., Wachtel M., Behnke S., Leuschner I., Niggli F.K., Schafer B.W. Histopathology 54:873-879(2009) · Mapped (33) |
| Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review. Qiu Y.Q., Leuschner I., Braun P.M. Asian J. Androl. 10:855-863(2008) · Mapped (11) |
| Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology. Royer-Pokora B., Weirich A., Schumacher V., Uschkereit C., Beier M., Leuschner I., Graf N., Autschbach F., Schneider D., von Harrach M. Cancer 113:1080-1089(2008) · Mapped (6) |
| High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Westermann F., Henrich K.O., Wei J.S., Lutz W., Fischer M., Konig R., Wiedemeyer R., Ehemann V., Brors B., Ernestus K. et al. Clin. Cancer Res. 13:4695-4703(2007) · Mapped (2) |
| Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children. Kazanowska B., Reich A., Stegmaier S., Bekassy A.N., Leuschner I., Chybicka A., Koscielniak E. Fetal Pediatr Pathol 26:17-31(2007) · Mapped (6) |
| Target genes of the WNT/beta-catenin pathway in Wilms tumors. Zirn B., Samans B., Wittmann S., Pietsch T., Leuschner I., Graf N., Gessler M. Genes Chromosomes Cancer 45:565-574(2006) · Mapped (2) |
| Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Koch A., Denkhaus D., Albrecht S., Leuschner I., von Schweinitz D., Pietsch T. Cancer Res. 59:269-273(1999) · UniProtKB (1) |